---
title: "Aakaar Medical Technologies Ltd (AAKAAR) — Share Price, Financials & Analysis"
symbol: "AAKAAR"
company: "Aakaar Medical Technologies Ltd"
canonical: "https://tapetide.com/stocks/AAKAAR"
isin: "INE1GYP01013"
nse_symbol: "AAKAAR"
sector: "Consumer Goods"
industry: "Personal Care"
market_cap_cr: 89.29
generated_at: "2026-09-13T19:02:46.130Z"
---

# Aakaar Medical Technologies Ltd (AAKAAR)

Canonical page: https://tapetide.com/stocks/AAKAAR

## Company

- **NSE Symbol:** AAKAAR
- **ISIN:** INE1GYP01013
- **Sector:** Consumer Goods
- **Industry:** Personal Care
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2025-06-27
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aakaarmedical.in

## About

Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]

## Latest Price

- **Price:** ₹63
- **Change:** 0 (0%)
- **Open:** ₹63
- **Day High:** ₹63
- **Day Low:** ₹63
- **Previous Close:** ₹63
- **Volume:** 3200
- **As Of:** 2026-09-11T06:50:52+00:00

## Key Fundamentals

Observed at 2026-09-11T04:40:27.665828Z.

- **Market Cap:** ₹89.29 Cr
- **Classification:** SME
- **P/E (reported):** 13.5
- **Book Value:** ₹38.49
- **Price to Book:** 1.64
- **Dividend Yield:** 0%
- **ROE:** 12.17%
- **ROCE:** 19.79%
- **Debt to Equity:** 0.34
- **Revenue (yearly):** ₹67.8 Cr
- **Net Income:** ₹6.6 Cr
- **EBITDA:** ₹11.1 Cr
- **52-Week High:** ₹96
- **52-Week Low:** ₹46
- **RSI (14):** 50.13

## Tapetide Score

- **Score:** 60 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 87.9 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 70.59 | 9% |
| growth | 50 | 9% |
| momentum | 63.42 | 12% |
| ownership | 66.67 | 24% |
| quality | 69.08 | 22% |
| valuation | 45.89 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 65.2% CAGR over last 5 years

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
- Working capital days have increased from 130 days to 199 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -54.53% | -3.98% | — |
| ebitda margin growth | 1.8% | 47.09% | 31.2% |
| net income growth | 10% | 46% | 65% |
| revenue growth | 9.71% | 27% | 40% |
| roce | -51.24% | -47.31% | 32.09% |
| roe | -53.08% | 20.33% | -39.63% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 33.88 | 25.32 | 41.64 |
| Expenses | 25.53 | 25.55 | 31.22 |
| Operating Profit | 8.35 | -0.23 | 10.42 |
| OPM % | 24.65 | -0.91 | 25.02 |
| Other Income | 0.11 | 0.3 | 0.63 |
| Interest | 0.91 | 1.04 | 0.76 |
| Depreciation | 0.07 | 0.05 | 0.08 |
| Profit before tax | 7.48 | -1.02 | 10.21 |
| Tax % | 25.53 | -23.53 | 27.33 |
| Net Profit | 5.57 | -0.78 | 7.42 |
| EPS in Rs | 5.34 | -0.55 | 5.24 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 |
| Expenses | 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.81 | 56.64 |
| Operating Profit | 2.88 | 0.9 | 2.4 | 3.53 | 5 | 9.77 | 10.32 |
| OPM % | 12.58 | 7.23 | 12.33 | 10.77 | 10.84 | 15.87 | 15.41 |
| Other Income | 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.8 |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.8 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 2.5 | 0.76 | 2.21 | 3.1 | 3.88 | 8.12 | 9.19 |
| Tax % | 26.8 | 28.95 | 26.24 | 30.65 | 26.29 | 25.62 | 27.86 |
| Net Profit | 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.03 | 6.64 |
| EPS in Rs | 183 | 54 | 23.14 | 30.71 | 41 | 5.79 | 4.69 |
| Dividend Payout % | 0 | 0 | 34.57 | 24.42 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.1 | 0.1 | 0.7 | 0.7 | 0.7 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.3 | 7.33 | 8.96 | 11.84 | 12.84 | 40.38 |
| Borrowings | 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 |
| Other Liabilities | 3.56 | 3.03 | 6.15 | 7.7 | 6.42 | 8.16 | 6.34 |
| Total Liabilities | 16.29 | 14.31 | 18 | 23.23 | 34.01 | 54.16 | 79.42 |
| Fixed Assets | 0.06 | 0.04 | 0.2 | 0.36 | 0.28 | 0.24 | 0.29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 |
| Investments | 0.47 | 0.11 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 15.76 | 14.16 | 17.8 | 22.87 | 33.73 | 53.92 | 78.73 |
| Total Assets | 16.29 | 14.31 | 18 | 23.23 | 34.01 | 54.16 | 79.42 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | -8.36 |
| Cash from Investing Activity | 0.1 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | 0.05 |
| Cash from Financing Activity | 0.28 | -2 | -0.81 | 1.17 | 8.19 | 10.71 | 18.8 |
| Net Cash Flow | 0 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | -0.4 | 4.3 | 0.29 | -3.19 | -8.09 | -5.49 | -8.94 |
| CFO/OP | 10 | 503 | 47 | -54 | -136 | -35 | -59 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 | 202.94 |
| Inventory Days | 234.33 | 366.16 | 281.7 | 273.75 | 247.29 | 202.47 | 255.63 |
| Days Payable | 28.2 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.1 | 344.26 | 319.59 | 434.24 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.79 | 198.91 |
| ROCE % | — | 8.25 | 20.93 | 25.79 | 23.28 | 26.72 | 18.46 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 91.12% | 67.01% | 67.05% |
| FIIs | 1.87% | 0% | 0% |
| DIIs | 0% | 0% | 11.17% |
| Government | 0% | 0% | 0% |
| Public | 0% | 16.47% | 15.99% |
| Others | 7.01% | 16.52% | 5.79% |
| No. of Shareholders | 11 | 603 | 550 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 6 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 63.3 | Sell |
| EMA (10) | 63.05 | Sell |
| SMA (20) | 61.77 | Buy |
| EMA (20) | 62.79 | Buy |
| SMA (50) | 64.9 | Sell |
| EMA (50) | 63.6 | Sell |
| SMA (100) | 63.87 | Sell |
| EMA (100) | 64.29 | Sell |
| SMA (200) | 65.38 | Sell |
| EMA (200) | 68.93 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.13 | Neutral |
| MACD (12,26,9) | 0.04 | Buy |
| Stochastic (14,3,3) | 29.62 | Neutral |
| ADX (14) | 10.73 | Neutral |
| Williams %R (14) | -74.44 | Neutral |
| ATR (14) | 2.1 | High Volatility |
| ROC (12) | -4.33 | Sell |
| Stoch RSI (14) | 15.21 | Buy |
| UO (7,14,28) | 55.53 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 May 2026 - SDD compliance certificate for FY ended 31 March 2026; 52 events captured, temporary issue resolved. | [Structural Digital Database 9 May 2026 - SDD compliance certificate for FY ended 31 March 2026; 52 events captured, temporary issue resolved.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_09052026123715_ComplianceCertificateSDDFY2526.pdf) |
| 9 Jul - Submitted June 30, 2026 share capital audit; all 1,41,72,816 shares fully dematerialized. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 Jul - Submitted June 30, 2026 share capital audit; all 1,41,72,816 shares fully dematerialized.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_09072026150150_Reg_76_Report.pdf) |
| 9 April 2026 - Regulation 74(5) compliance noted as not applicable for quarter ended March 31, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 April 2026 - Regulation 74(5) compliance noted as not applicable for quarter ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_09042026180309_Reg_74_5_.pdf) |
| 8 Sep - Management will attend a virtual investor meet with W.C. Securities on 15 September 2026. | [Analysts/Institutional Investor Meet/Con. Call Updates 8 Sep - Management will attend a virtual investor meet with W.C. Securities on 15 September 2026.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_08092026160826_Ltr2NSE080926.pdf) |
| 8 Jul - Regulation 74(5) non-applicability confirmed for quarter ended 30 June 2026; all shares held in demat form. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 Jul - Regulation 74(5) non-applicability confirmed for quarter ended 30 June 2026; all shares held in demat form.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_08072026151146_Reg74_5_Report.pdf) |
| 8 April 2026 - Annual promoter disclosure dated 08 Apr 2026 confirms no share encumbrance in FY2026. | [General Updates 8 April 2026 - Annual promoter disclosure dated 08 Apr 2026 confirms no share encumbrance in FY2026.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_08042026163620_Letter2NSE_Reg31_4_31032026.pdf) |
| 7 May 2026 - Aakaar Medical will host FY26 earnings call on May 15, 2026 at 4:30 PM IST after audited results. | [Analysts/Institutional Investor Meet/Con. Call Updates 7 May 2026 - Aakaar Medical will host FY26 earnings call on May 15, 2026 at 4:30 PM IST after audited results.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_07052026173856_EarningsCallIntimation150526.pdf) |
| 6 June 2026 - Newspaper publication issued for 13th AGM on 30 June 2026 via VC/OAVM. | [Copy of Newspaper Publication 6 June 2026 - Newspaper publication issued for 13th AGM on 30 June 2026 via VC/OAVM.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_06062026124935_FinalNewspaperPublication.pdf) |
| 5 June 2026 - 13th AGM on 30 June 2026; seek ESOPs up to 11,33,825 shares and capital increase to ₹15.40 crore. | [Shareholders meeting 5 June 2026 - 13th AGM on 30 June 2026; seek ESOPs up to 11,33,825 shares and capital increase to ₹15.40 crore.](https://nsearchives.nseindia.com/corporate/AAKAAR2025_05062026123435_NoticeofAGM.pdf) |
| 3m - Changed website to https://silverlinetechnologies.in/ from www.silverlinetechnology.com; notified 10-Mar-2026. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015. 3m - Changed website to https://silverlinetechnologies.in/ from www.silverlinetechnology.com; notified 10-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e75606a2-e9c4-4a54-a512-6158129a9509.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/AAKAAR2025_14112025160929_Transcriptsigned.pdf) |
| May 2026 | [Concall - May 2026](https://nsearchives.nseindia.com/corporate/AAKAAR2025_15052026162506_Final.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_29647_AAKAAR_2025_2026_A_1712600_08072026142531.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_29056_AAKAAR_2024_2025_A_29446359_16092025103215.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61e5e873-12eb-4e1a-830d-7ed3ab018c93.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbc536f7-5dae-4c46-b344-dc68bb7473e4.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5148646d-7272-4d93-8780-017e418b6f11.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/135a0a78-ca0c-439e-bcf1-8c62dd38dff3.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500389/72885500389.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500389/66675500389_16_10_20.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500389/63914500389.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500389/5003890318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:02:46.130Z.